CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 128 enrolled
Drug / intervention
Testing of the autocapture features of the device +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00746356
NCT00746356N/ACompleted

A Clinical Evaluation of the Current™ Radio Frequency (RF) Implantable Cardioverter Defibrillator (ICD) Models 2215/1215 and Promote™ RF Cardiac Resynchronization Therapy Defibrillator (CRT-D) Model 3215 Pulse Generators

Abbott Medical Devices·interventional·Posted Sep 4, 2008·Updated Feb 19, 2019

In Brief

A clinical study evaluating Testing of the autocapture features of the device for Heart Failure and Ventricular Arrythmias. Completed, enrolled 128 participants across 5 sites.

Detailed Summary

This study is a prospective, non-randomized, multi-center clinical trial that will assess the safety and effectiveness of investigational models of the Promote™ RF CRT-D and Current™ RF ICD devices. These new ICD and CRT-D devices have new features that allow the device to periodically check how much energy is needed to pace a patient's heart and to automatically adjust the amount of energy used to pace the heart.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 4, 2008
Enrollment StartAug 1, 2008
Primary CompletionMay 1, 2009
Study CompletionJan 1, 2010
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 17.8 years ago

Interventions

Testing of the autocapture features of the devicedevice

Patients receiving cardiac resynchronization therapy will have new autocapture features tested on right atrial, right ventricular and left ventricular leads.

Testing of the autocapture features of the devicedevice

Patients with an Implantable Cardioverter Defibrillator will have new autocapture features tested on the right atrial and right ventricular leads.